BioOhio takes 2014 Annual Conference “on the road” in series of three regional events

Posted by BioOhio on Sep. 15, 2014

AC-2014-Logo-Web-200Last autumn, Ohio’s bioscience industry convened its Annual Conference in its most central metropolis, Columbus. This year, however, BioOhio changes the scope of its Annual Conference by taking it “on the road.” Beginning September 18 in the Cincinnati area, BioOhio’s Annual Conference kicks-off a series of three regional meetings to reach Ohio’s bioscience members in their backyards – at the roots of Ohio’s bioscience industry.

In fact, the 2014 Annual Conference is titled, “Bioscience at its Roots: Members, Innovation, Growth” in recognition of the discoveries, commerce and connections that continue to grow the foundation of Ohio’s robust bioscience industry. “The BioOhio Board of Trustees and members who collaborated to create our Annual Conference are committed to this concept,” said John Lewis, President and CEO of BioOhio. “We find that when we travel to different corners of the state, we inevitably reach new people, discover new organizations and technologies, and learn new strategies to help us accelerate Ohio’s bioscience industry.”

The agenda for each of the three events draws heavily upon the experts and organizations native to each region in addressing region-specific concerns and opportunities. Jack Kraeutler, CEO of Cincinnati-based Meridian Bioscience, will participate in a panel on Transforming Healthcare. “We’re delighted to be involved in Ohio’s vibrant bioscience industry, and look forward to discussing opportunities and challenges that lie ahead. This event consistently offers excellent networking and enlightening content.”

(more…)

BioOhio’s Annual Conference Road Show brings Ohio’s Bioscience Community Together

Posted by BioOhio on Sep. 10, 2014
John F. Lewis, Jr. President & CEO

John F. Lewis, Jr.
President & CEO

For over 25 years, BioOhio has hosted an Annual Conference, and we are excited to take this year’s around the state, with regional events in Southern, Northern and Central Ohio. The theme of the three conferences focuses on the root of bioscience, including R&D, innovation, networking, and success stories.

The 2014 Annual Conference Road Show brings together Ohio’s clinical, research, commercial, economic development and funding professionals to chart the state of “Bio in Ohio,” and chart their own role in expanding Ohio’s bioscience future.

Thank you for making our industry strong and growing. As BioOhio’s President & CEO, I take pride in seeing so many motivated, engaged and supportive members. Please keep it up, and spread the word. We have an active Board of Trustees, so be sure to meet them because, along with our members, their strategic input is invaluable.

AC-2014-Logo-Web-200BioOhio members have asked for more networking, education, advocacy and talent-related services, and we responded to these requests. Members drive our activities, so let us know how we can keep improving and meeting your needs!

Share your accomplishments with us so we can make those stories more visible to the world. Please also provide us with testimonials about how BioOhio has helped you.

It is your engagement, participation and commitment that makes BioOhio a vibrant, valuable resource, and Ohio a great place to do business.

If you are not already registered to attend, click here to learn more and sign up today!

Enjoy the conference.

September is national aging month: AdvaMed presents resources on the importance of treatment for cataracts, osteoarthritis and diabetes

Posted by BioOhio on Sep. 09, 2014

advamed_lg_959_487_ from webIn recognition of National Aging Month, the Advanced Medical Technology Association (AdvaMed) has released resources on the benefit and patient value of treatments aimed at three major disease areas specific to the aging population: cataracts, osteoarthritis and diabetes.

These resources can be found at http://www.lifechanginginnovation.org/get-facts.

Cataracts Key Facts:

  • Cataracts affect 24.5 million Americans, and the prevalence of the disease is expected to increase significantly as the population ages. The cataract caseload is expected to rise 55 percent by 2020, and 104 percent by 2050.
  • Major vision problems cost the economy $35.4 billion a year.
  • Cataract surgery with intraocular lens technology – the only known treatment – improves vision and overall quality of life. Research has shown cataract surgery patients live longer; there is a 40 percent lower long-term mortality risk in those who have had the procedure.
  • Cataract surgery is cost-effective and provides great value to patients and the health care system. Estimates suggest that all cataract surgeries performed over the course of a single year save more than $123 billion over the subsequent thirteen years, and deliver a 4,567 percent financial return on investment to society.
  • View the full toolkit and infographic (pdf files).

Osteoarthritis Key Facts:

  • Osteoarthritis (OA) is a progressive, destructive disease of the major joints for which there is no cure. It is one of the leading causes of disability and functional limitation in the U.S.
  • Osteoarthritis impacts the economy by driving up employer and health costs. Bone and joint disorders, including OA, account for 440 million lost days at work and $110 billion in lost wages each year—more than any other medical condition.
  • Total joint replacement helps patients return to their lives and contributes to improved general health. Patients’ physical function is shown to improve by 79 percent after total hip replacement and 56 percent after total knee replacement.
  • Total knee replacement surgery generates net societal savings of approximately $19,000 per patient lifetime due to reduced disability costs and improved productivity. For all knee replacement surgeries performed in the U.S. in 2009, aggregate lifetime savings are estimated at $12 billion.
  • Hip and knee implants have shown a dramatic decline in price over the past six years, at 23 percent and 17 percent, respectively.
  • View the full toolkit and infographic (pdf files).

Diabetes Key Facts:

  • Nearly 26 million Americans are thought to have diabetes, and if recent trends continue, as many as one in three American adults could have diabetes by 2050.
  • Diabetes imposes a substantial economic burden on society and is one of the costliest chronic diseases. Diagnosed cases of diabetes cost the economy $245 billion in 2012.
  • Medical technologies, like advanced diagnostics, continuous glucose monitors and insulin pumps, have revolutionized the ways in which people are screened for and live with diabetes, providing diagnostic and treatment options that contribute to improved health outcomes and a better quality of life.
  • Insulin pumps alone can save individuals nearly $6,000 per year versus not using the device. Expanded investment in technology to treat diabetes will generate tremendous net economic savings over time – $225 billion over 25 years.
  • View the full toolkit and infographic (pdf files).

BIO Washington Update, September 2014

Posted by BioOhio on Sep. 09, 2014

CSBA BIO and Republic Consulting

September 9, 2014

Activity slowed in Washington last month as Congress left for the August District Work Period, though a host of issues are waiting for lawmakers upon their return on September 8. Below is a look at the outstanding legislative items Congress is expected to address in the coming weeks and during the Lame Duck session of the 113th Congress.

CONGRESSIONAL OUTLOOK FOR SEPTEMBER

Lawmakers will have a short timeframe to advance must-pass legislation now that they returned to DC. Currently, legislators are scheduled to be in Washington for only three weeks before departing for prime campaigning season, increasing the pressure to act on expiring legislation. Although Congress is not known for doing anything quickly, it is possible that the House and Senate come to an agreement on the must-pass items and cancel the final week of session, wrapping up legislative business around September 19.

Government Funding

The most pressing matter will be funding the federal government for Fiscal Year 2015 (FY15), which begins on October 1. Current funding for FY14 will expire on September 30, 2014, and the government may face another shutdown threat if congressional leaders cannot reach an agreement by then. (more…)

BioOhio Expo Showcases O-H-Bio in the Buckeye State

Posted by BioOhio on Sep. 03, 2014
Jennifer Goldsberry Manager, Member Services & Events

Jennifer Goldsberry
Manager, Member Services & Events

The Ohio Bioscience Expo & Showcase took over the Bertram Inn and Conference Center in Aurora when 275 attendees and 48 exhibitors converged for networking and business deals. Workshops were hosted by Offenberger & White, NanoLogix, UC ProPEL, McFlusion, Britton Gallagher, MAGNET, BioEnterprise, and Taylor Strategy Partners throughout the day, topics ranging from integrating internships into your company, additive manufacturing, marketing and social media, risk insurance, and microplate assays.

The event provided a venue for companies to showcase their innovations and technology, highlighting the vast bioscience foundation of the state. Exhibitors and attendees alike were able to connect or reconnect with customers, find new collaborators and partners, meet colleagues in the industry, discover companies making cutting edge products and delivering quality services.

Post-Event-Floor-1We’ve heard of several business deals as a result since the event, and many conversations are still underway.

Who was there? You can browse exhibitors in the Ohio Bioscience Resource Directory here, and check out pictures from around the event here.

Next on deck: The BioOhio Annual Conference Road Show, coming to a city near you this fall!

Post-Lexamed2 Post-Expo-Aff-Lang-Serv Post-Offenberger-White2

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Norwood Medical in Dayton planning $13.5M expansion, adding 50 jobs | Dayton Business Journal, September 17, 2014

Youngstown Business Incubator and TechColumbus 1st and 3rd university associated incubators in the world | UBI Index, September 16, 2014

Enable Injections featured in article on safer, simpler, smarter devices for drug delivery | Drug Development & Delivery, September 15, 2014

BioOhio takes 2014 Annual Conference “on the road” in series of three regional events | Business Wire, September 15, 2014

ABC’s of IND’s – ChanTest to Host Session at the Safety Pharmacology Society (SPS) Annual Meeting | PR Web, September 15, 2014

Nationwide Children’s Hospital discusses Enterovirus D68 | Nationwide Children's Hospital, September 12, 2014

Akebia Therapeutics (NASDAQ: AKBA) to ring the NASDAQ Stock Market Opening Bell | NASDAQ, September 11, 2014

$1M grant to Cincinnati Children’s intended to improve human growth and development around the world | CCHMC, September 10, 2014

Airway Therapeutics gets money to advance treatment for smallest and sickest babies | WCPO9 Cincinnati, September 10, 2014

Airway Therapeutics raises $4.6M in Series A financing | CincyTech, September 10, 2014

Airway Therapeutics announces $4.6M funding round | Cincinnati.com, September 10, 2014

Alkermes anti-addiction drug Vivitrol helping inmates at Barnstable County Correctional Facility (MA) | Boston Business Journal, September 8, 2014

Nationwide Children’s Hospital now home to the world’s largest Ronald McDonald House | Columbus Dispatch, September 8, 2014

Envision Pharmaceutical completes its acquisition of MedTrak Services (Kansas) | Herald Online, September 8, 2014

Ohio Capital Fund key player in state startup scene | Cincinnati.com, September 6, 2014

Navidea enters Lymphoseek development and commercialization agreement with Hainan Sinotau Pharmaceutical Co., Ltd. subsidiary in China | Navidea Pharmaceuticals, September 4, 2014

Ricerca Biosciences in discussions to be acquired | OutsourcingPharma.com, September 3, 2014

Meridian Bioscience signs agreement with Premier to offer its hospitals molecular diagnostic tests and instruments | Business Wire, September 3, 2014

Cleveland Functional Electrical Stimulation Center taking toy donations at Expo to help disabled children | WKYC3 NBC, September 2, 2014

Aerpio Therapeutics announces publication of preclinical data on AKB-9778 for common eye diseases | Business Wire, September 2, 2014